10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64 | -19.0% | 1,546 | +8.8% | 0.00% | – |
| Q2 2023 | $79 | -13.2% | 1,421 | -12.9% | 0.00% | – |
| Q1 2023 | $91 | +62.5% | 1,632 | +7.0% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 1,525 | +15.1% | 0.00% | – |
| Q3 2022 | $38,000 | -99.0% | 1,325 | -98.5% | 0.00% | -100.0% |
| Q2 2022 | $3,990,000 | -33.7% | 88,179 | +11.5% | 0.01% | -8.3% |
| Q1 2022 | $6,014,000 | -35.6% | 79,055 | +26.1% | 0.01% | -45.5% |
| Q4 2021 | $9,338,000 | -1.0% | 62,691 | -3.2% | 0.02% | -8.3% |
| Q3 2021 | $9,431,000 | -43.0% | 64,782 | -23.3% | 0.02% | -38.5% |
| Q2 2021 | $16,543,000 | +0.1% | 84,483 | -7.4% | 0.04% | -13.3% |
| Q1 2021 | $16,522,000 | – | 91,281 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |